{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:16:05Z","timestamp":1781529365226,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clinbiochem.2021.04.018","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T02:44:40Z","timestamp":1619145880000},"page":"62-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7546-393X","authenticated-orcid":false,"given":"Christine A.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Sarabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine P.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McCudden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clinbiochem.2021.04.018_b0005","first-page":"1","article-title":"Clinical practice guideline update for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder","volume":"2017","author":"KDIGO","year":"2017","journal-title":"Kidney Int. Suppl."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.04.018_b0010","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.04.018_b0015","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfr535","article-title":"Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values","volume":"27","author":"Cavalier","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.04.018_b0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/acb.2011.011094","article-title":"Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease","volume":"49","author":"Almond","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1515\/CCLM.2009.068","article-title":"Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods","volume":"47","author":"Monge","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0035","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1373\/clinchem.2006.071589","article-title":"Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions","volume":"52","author":"Cantor","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0040","unstructured":"Renal Association Clinical Practice Guideline:CKD-Mineral and Bone Disorders. Available at: http:\\\\www.renal.org\/clinical\/GuidelinesSection\/CKD-BMD.aspx. Accessed: Dec 2020."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0045","unstructured":"Institute for Quality Management in Health Care. Available at: https:\/\/iqmh.org\/. Accessed Dec 2020."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0050","unstructured":"Standardization13528 IOf. Statistical Methods for Use in Proficiency Testing by Interlaboratory Comparison, Standardization IOf, Editor 2015."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0055","first-page":"3086","article-title":"Vitamin D status and redefining serum parathyroid hormone reference range in the elderly","volume":"86","author":"Souberbielle","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.clinbiochem.2021.04.018_b0060","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/ndt\/gfr614","article-title":"Variation in parathyroid hormone immunoassay results\u2013a critical governance issue in the management of chronic kidney disease","volume":"26","author":"Sturgeon","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0065","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2002-021266","article-title":"Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism","volume":"88","author":"Silverberg","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.04.018_b0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/10408363.2017.1379945","article-title":"The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper","volume":"54","author":"Adeli","year":"2017","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.04.018_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1258\/acb.2011.011254","article-title":"Parathyroid hormone measurements, guidelines statements and clinical treatments: a real-world cautionary tale","volume":"49","author":"Garrett","year":"2012","journal-title":"Ann. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.04.018_b0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.09580911","article-title":"PTH\u2013a particularly tricky hormone: why measure it at all in kidney patients?","volume":"8","author":"Garrett","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cca.2016.10.016","article-title":"Perspective and priorities for improvement of parathyroid hormone (PTH) measurement \u2013 a view from the IFCC Working Group for PTH","volume":"467","author":"Sturgeon","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2021.04.018_b0090","unstructured":"International Federation of Clinical Chemistry and Laboratroy Medicine. Bone Metabolism Working Group. Available at: https:\/\/www.ifcc.org\/ifcc-scientific-division\/sd-committees\/c-bm\/. Accessed: January 05, 2021."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:57:47Z","timestamp":1757865467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021001211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":18,"alternative-id":["S0009912021001211"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.04.018","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}